Latest Insider Transactions at Icosavax, Inc. (ICVX)
This section provides a real-time view of insider transactions for Icosavax, Inc. (ICVX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Icosavax, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Icosavax, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Adam K. Simpson |
BUY
Bona fide gift
|
Indirect |
250,000
+49.21%
|
-
|
|
Dec 21
2021
|
Adam K. Simpson |
SELL
Bona fide gift
|
Indirect |
250,000
-17.52%
|
-
|
|
Nov 15
2021
|
Cassia Cearley |
BUY
Exercise of conversion of derivative security
|
Direct |
22,598
+20.91%
|
$0
$0.83 P/Share
|
|
Aug 02
2021
|
Nano Dimension Iii, L.P. |
BUY
Open market or private purchase
|
Direct |
133,334
+4.42%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Nano Dimension Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,749,995
+50.0%
|
-
|
|
Aug 02
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
426,393
+50.0%
|
-
|
|
Aug 02
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,666,666
+26.93%
|
$39,999,990
$15.0 P/Share
|
|
Aug 02
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
3,112,681
+50.0%
|
-
|
|
Aug 02
2021
|
Adams Street Partners LLC |
BUY
Open market or private purchase
|
Indirect |
133,334
+4.6%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Adams Street Partners LLC |
BUY
Conversion of derivative security
|
Indirect |
3,259,058
+50.0%
|
-
|
|
Aug 02
2021
|
Terry P Gould Director |
BUY
Open market or private purchase
|
Indirect |
133,334
+4.6%
|
$2,000,010
$15.0 P/Share
|
|
Aug 02
2021
|
Terry P Gould Director |
BUY
Conversion of derivative security
|
Indirect |
3,259,058
+50.0%
|
-
|
|
Aug 02
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. |
BUY
Open market or private purchase
|
Direct |
221,351
+2.0%
|
$3,320,265
$15.0 P/Share
|
|
Aug 02
2021
|
Qiming U.S. Healthcare Fund Ii, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,310,228
+50.0%
|
-
|
|
Aug 02
2021
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
66,667
+2.07%
|
$1,000,005
$15.0 P/Share
|
|
Aug 02
2021
|
Sanofi > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,088,502
+50.0%
|
-
|
|
Aug 02
2021
|
Niranjan Kanesa Thasan |
BUY
Open market or private purchase
|
Direct |
6,666
+50.0%
|
$99,990
$15.0 P/Share
|
|
Aug 02
2021
|
Douglas Holtzman Chief Scientific Officer |
BUY
Conversion of derivative security
|
Indirect |
52,440
+50.0%
|
-
|
|
Jul 30
2021
|
Thomas Joseph Russo |
BUY
Grant, award, or other acquisition
|
Direct |
32,500
+50.0%
|
$487,500
$15.0 P/Share
|
|
Jul 30
2021
|
Niranjan Kanesa Thasan |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+19.75%
|
$622,500
$15.0 P/Share
|
|
Jul 30
2021
|
Adam K. Simpson |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
$1,875,000
$15.0 P/Share
|
|
Jul 30
2021
|
Heidi Fields |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+50.0%
|
$131,250
$15.0 P/Share
|
|
Jul 30
2021
|
Douglas Holtzman Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+12.81%
|
$622,500
$15.0 P/Share
|
|
Jul 30
2021
|
Ann M Veneman |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+50.0%
|
$127,500
$15.0 P/Share
|
|
Jul 30
2021
|
Cassia Cearley |
BUY
Grant, award, or other acquisition
|
Direct |
27,750
+30.61%
|
$416,250
$15.0 P/Share
|
|
Jul 30
2021
|
Charles E Richardson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
27,750
+26.02%
|
$416,250
$15.0 P/Share
|